Cargando…
Persistence of HBsAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults
The duration of protection after hepatitis B vaccination is not exactly known. This phase IV study evaluated antibody persistence and immune memory 20‐30 years after adult immunization with recombinant hepatitis B vaccine (HBsAg vaccine, Engerix‐B) in routine clinical practice. Men and women 40‐60 y...
Autores principales: | Van Damme, Pierre, Dionne, Marc, Leroux‐Roels, Geert, Van Der Meeren, Olivier, Di Paolo, Emmanuel, Salaun, Bruno, Surya Kiran, Pemmaraju, Folschweiller, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852111/ https://www.ncbi.nlm.nih.gov/pubmed/31087382 http://dx.doi.org/10.1111/jvh.13125 |
Ejemplares similares
-
Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers
por: Poovorawan, Yong, et al.
Publicado: (2012) -
Performance Evaluation of an Improved HBsAg Assay (HBsAg NEXT) for the Detection of HBsAg Levels
por: Gupta, Ekta, et al.
Publicado: (2023) -
Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine
por: Van Damme, Pierre, et al.
Publicado: (2017) -
A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection
por: Burm, Rani, et al.
Publicado: (2022) -
Comparison of the Clinical Features of Hepatitis A between HBsAg-Positive and HBsAg-Negative Patients
por: Kim, Kwang Min, et al.
Publicado: (2011)